Tissue factor-bearing microparticles and cancer-associated thrombosis

Published: June 3, 2009
Abstract Views: 201
Untitled (): 0
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Microparticles were first described in normal blood as platelet dust.1 Sims carefully studied the generation of platelet microparticles during platelet activation by complement.2 These platelet microparticles bind to Factor Va and support prothrombinase activity3 as well as bind to Factor VIII.4 Since these reports, hundreds of studies have monitored microparticles, primarily using flow cytometry and light scattering, and correlated microparticle antigen expression within diverse groups of diseases. However, microparticles have been subjected to limited chemical analysis, including their lipid and protein content.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Supporting Agencies

How to Cite

Furie, B. (2009). Tissue factor-bearing microparticles and cancer-associated thrombosis. Hematology Meeting Reports (formerly Haematologica Reports), 1(9). https://doi.org/10.4081/hmr.v1i9.311